Ryosuke Matsuda

1.8k total citations
116 papers, 1.2k citations indexed

About

Ryosuke Matsuda is a scholar working on Neurology, Epidemiology and Surgery. According to data from OpenAlex, Ryosuke Matsuda has authored 116 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 32 papers in Epidemiology and 29 papers in Surgery. Recurrent topics in Ryosuke Matsuda's work include Meningioma and schwannoma management (25 papers), Glioma Diagnosis and Treatment (20 papers) and Immune Cell Function and Interaction (16 papers). Ryosuke Matsuda is often cited by papers focused on Meningioma and schwannoma management (25 papers), Glioma Diagnosis and Treatment (20 papers) and Immune Cell Function and Interaction (16 papers). Ryosuke Matsuda collaborates with scholars based in Japan, France and United States. Ryosuke Matsuda's co-authors include Hiroyuki Nakase, Ichiro Nakagawa, Fumihiko Nishimura, Yasushi Motoyama, Hugues Duffau, Alejandro Fernández Coello, Mitsutoshi Nakamura, Tsutomu Nakazawa, Yasuhiro Takeshima and Young-Soo Park and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ryosuke Matsuda

97 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Matsuda Japan 19 330 298 258 250 219 116 1.2k
Young-Soo Park Japan 18 396 1.2× 267 0.9× 207 0.8× 100 0.4× 141 0.6× 101 1.1k
Qiang Zhao China 17 187 0.6× 70 0.2× 222 0.9× 179 0.7× 130 0.6× 80 1.0k
Andrea Carai Italy 22 184 0.6× 88 0.3× 260 1.0× 545 2.2× 395 1.8× 113 1.5k
Güliz Acker Germany 19 112 0.3× 193 0.6× 203 0.8× 211 0.8× 366 1.7× 62 1.1k
Tal Shahar Israel 20 146 0.4× 80 0.3× 215 0.8× 612 2.4× 198 0.9× 44 1.6k
Manon M. H. Huibers Netherlands 23 210 0.6× 154 0.5× 274 1.1× 141 0.6× 128 0.6× 38 1.4k
Geralyn Annett United States 17 421 1.3× 303 1.0× 196 0.8× 442 1.8× 100 0.5× 22 1.7k
Alberto Feletti Italy 19 197 0.6× 85 0.3× 178 0.7× 214 0.9× 273 1.2× 77 1.0k
Valeria Cuccarini Italy 20 139 0.4× 106 0.4× 100 0.4× 335 1.3× 146 0.7× 46 909
Dominique Figarella‐Branger France 15 105 0.3× 70 0.2× 90 0.3× 495 2.0× 166 0.8× 20 1.0k

Countries citing papers authored by Ryosuke Matsuda

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Matsuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Matsuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Matsuda more than expected).

Fields of papers citing papers by Ryosuke Matsuda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Matsuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Matsuda. The network helps show where Ryosuke Matsuda may publish in the future.

Co-authorship network of co-authors of Ryosuke Matsuda

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Matsuda. A scholar is included among the top collaborators of Ryosuke Matsuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Matsuda. Ryosuke Matsuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuda, Ryosuke, Tetsuro Tamamoto, Shigeto Hontsu, et al.. (2025). Systemic inflammation response index predicts overall survival in patients undergoing stereotactic radiosurgery for brain metastasis from non-small cell lung cancer. Journal of Radiation Research. 66(2). 129–136.
2.
Matsuda, Ryosuke, Tsutomu Nakazawa, Yuki Mochida, et al.. (2025). Immunotherapy using allogenic NK cells downregulates mitochondrial-related genes and inhibits the OXPHOS system of malignant meningioma. Biomedicine & Pharmacotherapy. 187. 118099–118099.
3.
Nakajima, Riho, Masashi Kinoshita, Seiichiro Hirono, et al.. (2025). Intraoperative Assessment of Right Cingulum Function Using the Williams Inhibition Test During Awake Surgery for Right Frontal Gliomas. World Neurosurgery. 201. 124266–124266.
4.
Matsuda, Ryosuke, Maiko Takeda, Tomomi Fujii, et al.. (2024). Successful dabrafenib and trametinib combination therapy in a patient with recurrent BRAFV600E‐mutant non‐small‐cell lung cancer and coexisting radiation pneumonitis. SHILAP Revista de lepidopterología. 12(1). e01277–e01277. 1 indexed citations
5.
Matsuda, Ryosuke, et al.. (2024). Lynch Syndrome-Associated Glioblastoma Treated With Concomitant Chemoradiotherapy and Immune Checkpoint Inhibitors: Case Report and Review of Literature. Brain Tumor Research and Treatment. 12(1). 70–70. 1 indexed citations
6.
Matsuda, Ryosuke, et al.. (2024). Awake Surgery for Angiocentric Glioma in the Eloquent Area in an Adolescent: A Case Report. Brain Tumor Research and Treatment. 12(1). 75–75.
7.
Nakazawa, Tsutomu, Takayuki Morimoto, Kengo Yamada, et al.. (2024). Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma. International Journal of Molecular Sciences. 25(11). 5896–5896. 2 indexed citations
8.
Morimoto, Takayuki, Tsutomu Nakazawa, Ryosuke Matsuda, et al.. (2024). Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis. International Journal of Molecular Sciences. 25(4). 2435–2435.
9.
Morimoto, Takayuki, Tsutomu Nakazawa, Ryosuke Matsuda, et al.. (2024). Bulk RNA sequencing reveals the comprehensive genetic characteristics of human cord blood-derived natural killer cells. Regenerative Therapy. 25. 367–376. 1 indexed citations
10.
Morimoto, Takayuki, et al.. (2023). Natural Killer Cell-Based Immunotherapy against Glioblastoma. International Journal of Molecular Sciences. 24(3). 2111–2111. 30 indexed citations
11.
Nakazawa, Tsutomu, Takayuki Morimoto, Ryosuke Matsuda, et al.. (2023). An efficient feeder-free and chemically-defined expansion strategy for highly purified natural killer cells derived from human cord blood. Regenerative Therapy. 24. 32–42. 7 indexed citations
12.
Nakagawa, Ichiro, Masashi Kotsugi, Shohei Yokoyama, et al.. (2023). Dual-layered stents reduce cerebral embolism compared with first-generation stents during carotid stenting of high lipid core plaque lesions. Journal of NeuroInterventional Surgery. 16(1). 67–72. 2 indexed citations
13.
Ouji, Yukiteru, Tsutomu Nakazawa, Ryosuke Matsuda, et al.. (2023). Local administration of shikonin improved the overall survival in orthotopic murine glioblastoma models with temozolomide resistance. Biomedicine & Pharmacotherapy. 166. 115296–115296. 4 indexed citations
14.
Nakagawa, Ichiro, Masashi Kotsugi, Shohei Yokoyama, et al.. (2023). Parenchymal Blood Volume Changes Immediately After Endovascular Thrombectomy Predict Futile Recanalization in Patients with Emergent Large Vessel Occlusion. World Neurosurgery. 176. e711–e718. 1 indexed citations
15.
Nakazawa, Tsutomu, Ryosuke Matsuda, Takayuki Morimoto, et al.. (2023). Therapeutic Anti-KIR Antibody of 1–7F9 Attenuates the Antitumor Effects of Expanded and Activated Human Primary Natural Killer Cells on In Vitro Glioblastoma-like Cells and Orthotopic Tumors Derived Therefrom. International Journal of Molecular Sciences. 24(18). 14183–14183. 2 indexed citations
16.
Nakazawa, Tsutomu, Takayuki Morimoto, Ryosuke Matsuda, et al.. (2022). Capability of Human Dendritic Cells Pulsed with Autologous Induced Pluripotent Stem Cell Lysate to Induce Cytotoxic T Lymphocytes against HLA-A33-Matched Cancer Cells. International Journal of Molecular Sciences. 23(21). 12992–12992. 7 indexed citations
17.
Matsuda, Ryosuke, Noriaki Tokuda, Tsutomu Nakazawa, et al.. (2022). Intraoperative Ventricular Opening has No Effect on Complication Development Following BCNU Wafer Implantation for Malignant Glioma. World Neurosurgery. 171. e707–e713. 2 indexed citations
18.
Nakazawa, Tsutomu, Ryosuke Matsuda, Takayuki Morimoto, et al.. (2021). Ex Vivo Expanded and Activated Natural Killer Cells Prolong the Overall Survival of Mice with Glioblastoma-like Cell-Derived Tumors. International Journal of Molecular Sciences. 22(18). 9975–9975. 11 indexed citations
19.
Tanaka, Yoshitaka, Tsutomu Nakazawa, Mitsutoshi Nakamura, et al.. (2019). Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro. PLoS ONE. 14(3). e0212455–e0212455. 32 indexed citations
20.
Matsuda, Ryosuke, et al.. (2018). Glioblastoma Mimicking Subarachnoid Hemorrhage of Unknown Etiology: A Case Report. World Neurosurgery. 120. 54–58. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026